Vol 24, No 2 (2017)
Letters to the Editor — Clinical cardiology
Published online: 2017-04-14
Left ventricular improvement due to allogeneic CB-MNCs transplantation in a chronic heart failure six-years after myocardial infarction
Abstract
Not available
References
- Honold J, Fischer-Rasokat U, Seeger FH, et al. Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure. Clin Res Cardiol. 2013; 102(9): 619–625.
- Krumholz H, Anderson J, Bachelder B, et al. ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction. Circulation. 2008; 118: 2596–2648.
- Giugliano RP, Braunwald E. 2004 ACC/AHA guideline for the management of patients with STEMI: the implications for clinicians. Nat Clin Pract Cardiovasc Med. 2005; 2(3): 114–115.
- Yousef M, Schannwell CM, Köstering M, et al. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol. 2009; 53(24): 2262–2269.
